Europe — EMA

Palonosetron Fresenius Kabi (Palonosetron Hydrochloride)

Palonosetron Hydrochloride, the active ingredient in Palonosetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use.

Palonosetron Hydrochloride

Request sourcing

Pack/s

What is Palonosetron Hydrochloride?

Palonosetron Hydrochloride, the active ingredient in Palonosetron Fresenius Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is employed to prevent nausea and vomiting associated with chemotherapy and postoperative settings in adult patients. GNH USA supplies Palonosetron Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Palonosetron Fresenius Kabi as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Palonosetron Hydrochloride used for?

Palonosetron Fresenius Kabi is a 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways related to cancer therapy and surgery.

- Chemotherapy‑induced nausea and vomiting (CINV): Provides prophylactic control of acute and delayed CINV in adult patients. - Post‑operative nausea and vomiting (PONV): Reduces the incidence of nausea and vomiting after surgical procedures. - Radiotherapy‑induced nausea and vomiting: Helps the ... (...) - ... ...

What are the side effects of Palonosetron Hydrochloride?

Common ...

What precautions apply to Palonosetron Hydrochloride?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →